|
|
|
|
Size
|
Re: glycoprotein builder
|
Lachele Foley <[log in to unmask]> |
Wed, 5 Apr 2017 00:09:30 -0400 |
404 lines |
Re: glycoprotein builder
|
Hallel Freedman <[log in to unmask]> |
Tue, 4 Apr 2017 16:12:30 -0600 |
364 lines |
Re: glycoprotein builder
|
Hallel Freedman <[log in to unmask]> |
Tue, 4 Apr 2017 16:07:20 -0600 |
339 lines |
Re: glycoprotein builder
|
Hallel Freedman <[log in to unmask]> |
Tue, 4 Apr 2017 14:14:54 -0600 |
273 lines |
Re: glycoprotein builder
|
Lachele Foley <[log in to unmask]> |
Mon, 3 Apr 2017 22:58:53 -0400 |
249 lines |
Re: glycoprotein builder
|
Hallel Freedman <[log in to unmask]> |
Mon, 3 Apr 2017 11:05:18 -0600 |
217 lines |
Re: glycoprotein builder
|
Lachele Foley <[log in to unmask]> |
Mon, 3 Apr 2017 09:11:49 -0400 |
192 lines |
Re: glycoprotein builder
|
Lachele Foley <[log in to unmask]> |
Mon, 3 Apr 2017 09:05:53 -0400 |
8453 lines |
Re: Heparin in AMBER
|
Neha S. Gandhi <[log in to unmask]> |
Thu, 27 Apr 2017 06:27:23 +0000 |
480 lines |
Re: Heparin in AMBER
|
Xiaocong Wang <[log in to unmask]> |
Tue, 25 Apr 2017 02:38:14 +0000 |
219 lines |
Re: Heparin in AMBER
|
Sushil Mishra <[log in to unmask]> |
Tue, 25 Apr 2017 10:31:04 +0900 |
107 lines |
Re: Heparin in AMBER
|
David Thieker <[log in to unmask]> |
Mon, 24 Apr 2017 10:56:15 -0400 |
171 lines |
Heparin in AMBER
|
Neha Gandhi <[log in to unmask]> |
Sun, 23 Apr 2017 23:22:16 -0400 |
708 lines |
